Speaker illustration

Associate Professor Jonathan Piccini

Duke Clinical Research Institute, Durham (United States of America)

Member of:

European Society of Cardiology

Two-Year Outcomes with Leadless Pacing- Micra CED Results

Event: ESC Congress 2021 - The Digital Experience

Topic: Antibradycardia Pacing

Session: Late Breaking Science in Arrhythmias

Thumbnail

Association of Inappropriate Dosing of Non-Vitamin K Oral Anticoagulants and Risk of Adverse Events: Results from the ORBIT-AF II Registry

Event: ESC CONGRESS 2016

Topic: Atrial fibrillation (AF)

Session: Registries atrial fibrillation

Thumbnail

Pharmacotherapy for atrial fibrillation in patients with chronic kidney disease: insights from the outcomes registry for better informed treatment of atrial fibrillation (ORBIT AF)

Event: ESC CONGRESS 2016

Topic: Antiarrhythmic drugs

Session: Miscellaneous in arrhythmia

Thumbnail

Net clinical benefit of rivaroxaban compared with warfarin in patients with atrial fibrillation

Event: ESC CONGRESS 2016

Topic: Atrial fibrillation (AF)

Session: Anticoagulation in atrial fibrillation II

Thumbnail

This platform is supported by

logo Novo Nordisk